The American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) has released updated Clinical Indicators for the public and physicians. Clinical indicators for otolaryngology serve as a checklist for practitioners and a quality care review tool for clinical departments. The Clinical Indicators are created by the AAO-HNS and its clinical committees. "Clinical Indicators define a basis of medical necessity for a range of procedures...their intent is to help practitioners engage in the best practices, reduce errors and improve value of care received as much as humanly possible," said Richard Waguespack, MD, Coordinator for Socioeconomic Affairs and Co-Chair of the Physician Payment Policy (3P) Workgroup that led the revision effort. "They also include procedure-specific post-operative observations, outcome issues suggested for use by institutions and surgeons, and a patient information section that physicians can use during surgical counseling." The newly updated indicators include: Endoscopic Sinus Surgery, Nasal Endoscopy, Canalith Repositioning, Tonsillectomy, Adenoidectomy, and Adentonsillectomy, Septoplasty, Adenoidectomy, Laryngoscope/ Nasopharyngoscopy, Endoscopic Sinus Surgery: Pediatric, and Neck Dissection. These indicators are intended as suggestions, not rules, and should be modified by users when deemed medically necessary based on clinical judgment and expertise.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor